<?xml version="1.0" encoding="UTF-8"?>
<!-- Generator: Adobe Illustrator 16.0.0, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg version="1.1" id="Capa_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" width="893px" height="679.5px" viewBox="0 0 893 679.5" enable-background="new 0 0 893 679.5" xml:space="preserve">
<rect y="186.219" opacity="0.4" fill="#D7AE1A" width="893" height="60.953"/>
<rect x="23.277" y="-9.553" fill="none" width="438.723" height="43.341"/>
<text class="title" transform="matrix(1 0 0 1 24.9585 38.7676)" fill="#1D1D1B" font-family="Robot" font-weight="700" font-size="30">Main Zika Vaccine Candidates</text>
<image width="98" height="40" y="10" x="800" xlink:href=" data:image/png;base64,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"/>
<path d="M72.018,205.271"/>
<rect y="54.73" opacity="0.7" fill="#D7AE1A" width="893" height="56"/>
<text transform="matrix(1 0 0 1 49 88.416)" font-family="Robot" font-weight="700" font-size="14">Institution/company</text>
<text transform="matrix(1 0 0 1 272.5161 88.749)" font-family="Robot" font-weight="700" font-size="14">Country</text>
<text transform="matrix(1 0 0 1 396 87.6152)" font-family="Robot" font-weight="700" font-size="14">Therapeutic approach</text>
<text transform="matrix(1 0 0 1 675 88.749)" font-family="Robot" font-weight="700" font-size="14">Phase of development</text>
<text class="r1" transform="matrix(1 0 0 1 48.9995 146.4092)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">National Institute of Alergy </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">and Infectious Diseases</tspan>
</text>
<text class="r1" transform="matrix(1 0 0 1 272.5161 153.0088)" font-family="Robot" font-size="11">USA</text>
<text class="r1" textLength="800" transform="matrix(1 0 0 1 396 126.6094)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Dos candidatos:</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-DNA vaccine based on the West</tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">Nile virus vaccine model</tspan>
  <tspan x="0" y="39.6" font-family="Robot" font-size="11">-Live attenuated virus vaccine, based </tspan>
  <tspan x="0" y="52.8" font-family="Robot" font-size="11">on the Dengue virus vaccine model </tspan>
</text>
<text class="r1" transform="matrix(1 0 0 1 675 153.0088)" font-family="Robot" font-size="11">Preclinical (in animals)</text>
<text class="r6" transform="matrix(1 0 0 1 675 465.625)" font-family="Robot" font-size="11">Preclinical</text>
<text class="r3" transform="matrix(1 0 0 1 675 278.1865)" font-family="Robot" font-size="11">Preclinical</text>
<text class="r2" transform="matrix(1 0 0 1 48.9995 219.9102)" font-family="Robot" font-size="11">Butantan Institute (Sao Paolo)</text>
<text class="r2" transform="matrix(1 0 0 1 272.5161 219.9102)" font-family="Robot" font-size="11">Brazil</text>
<text class="r2" transform="matrix(1 0 0 1 396 200.1104)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Two candidates:</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-Inactivated virus vaccine</tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">-Live attenuated virus vaccine</tspan>
  <tspan x="0" y="39.6" font-family="Robot" font-size="11">in collaboration with the NIH, USA</tspan>
</text>
<text class="r2" transform="matrix(1 0 0 1 675 219.9102)" font-family="Robot" font-size="11">Virus culture</text>
<rect y="627.594" opacity="0.7" fill="#D7AE1A" width="893" height="4"/>
<rect y="391.521" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect x="1" y="484.297" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect x="9.565" y="788.68" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect y="579.905" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect y="296.352" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<text class="r3" transform="matrix(1 0 0 1 48.999 278.1865)" font-family="Robot" font-size="11">Jenner Institute (Oxford)</text>
<text class="r3" transform="matrix(1 0 0 1 272.5161 278.1865)" font-family="Robot" font-size="11">Great Britain</text>
<text class="r3" textLength="400" transform="matrix(1 0 0 1 396 271.5869)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Non-replicative adenovirus expressing </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">Zika virus surface proteins</tspan>
</text>
<text class="r4" transform="matrix(1 0 0 1 48.9985 323.2939)" font-family="Robot" font-size="11">Bharat BioTech (Hyderabad)</text>
<text class="r4" transform="matrix(1 0 0 1 272.5161 323.2939)" font-family="Robot" font-size="11">India</text>
<text class="r4" transform="matrix(1 0 0 1 675 323.2949)" font-family="Robot" font-size="11">Preclinical studies</text>
<text class="r4" textLength="500" transform="matrix(1 0 0 1 396 310.0947)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Two candidates:</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-Inactivated virus vaccine</tspan>
  <tspan x="0" y="26.399" font-family="Robot" font-size="11">-Recombinant vaccine with viral surface proteins</tspan>
</text>
<text class="r5" transform="matrix(1 0 0 1 48.998 358.0859)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Inovio Pharmaceuticals </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">(Pennsylvania) </tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">GeneOne Life Science (Seoul)</tspan>
</text>
<text class="r5" transform="matrix(1 0 0 1 272.5161 364.6865)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">USA</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">South Korea</tspan>
</text>
<text class="r5" textLength="400" transform="matrix(1 0 0 1 396 364.6855)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">DNA vaccines that code for capsid </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">and surface viral proteins</tspan>
</text>
<text class="r5" textLength="550" transform="matrix(1 0 0 1 675 358.0859)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">-In preclinical studies since 3T 2015</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-Phase I clinical studies (in humans) </tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">planned for 4T 2016</tspan>
</text>
<text class="r10" transform="matrix(1 0 0 1 48.998 418.4648)" font-family="Robot" font-size="11">Sanofi Pasteur (Lyon)</text>
<text class="r6" transform="matrix(1 0 0 1 48.998 465.625)" font-family="Robot" font-size="11">Hawaii Biotech (Honolulu)</text>
<text class="r7" transform="matrix(1 0 0 1 49 504.6406)"><tspan x="0" y="0" font-family="Robot" font-size="11">Protein Sciences Corporation </tspan><tspan x="0" y="13.2" font-family="Robot" font-size="11">(Connecticut)</tspan></text>
<text class="r8" transform="matrix(1 0 0 1 48.998 558.665)" font-family="Robot" font-size="11">NewLinks Genetics (Iowa)</text>
<text class="r9" transform="matrix(1 0 0 1 48.998 606.8477)" font-family="Robot" font-size="11">PaxVax (California)</text>
<text class="r6" transform="matrix(1 0 0 1 272.5161 465.625)" font-family="Robot" font-size="11">USA</text>
<text class="r7" transform="matrix(1 0 0 1 272.5161 511.2402)" font-family="Robot" font-size="11">USA</text>
<text class="r8" transform="matrix(1 0 0 1 272.5161 558.665)" font-family="Robot" font-size="11">USA</text>
<text class="r9" transform="matrix(1 0 0 1 272.5161 606.8477)" font-family="Robot" font-size="11">USA</text>
<text class="r10" transform="matrix(1 0 0 1 272.5161 418.4648)" font-family="Robot" font-size="11">France</text>
<text class="r10" transform="matrix(1 0 0 1 396 418.4648)" font-family="Robot" font-size="11">Recombinant attenuated virus vaccine</text>
<text class="r6" textLength="360" transform="matrix(1 0 0 1 396 459.0244)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Non-replicative vaccines based on recombinant </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">viral subunits</tspan>
</text>
<text class="r7" textLength="300" transform="matrix(1 0 0 1 675 504.6406)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Clinical studies to start in </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">following months</tspan>
</text>
<text class="r7" transform="matrix(1 0 0 1 396 511.2402)" font-family="Robot" font-size="11">Recombinant protein vaccine</text>
<text class="r8" transform="matrix(1 0 0 1 675 558.665)" font-family="Robot" font-size="11">Unknown</text>
<text class="r8" transform="matrix(1 0 0 1 396 558.666)" font-family="Robot" font-size="11">Complete inactivated virus vaccine</text>
<text class="r9" transform="matrix(1 0 0 1 675 600.248)"><tspan x="0" y="0" font-family="Robot" font-size="11">Planning preclinical studies</tspan><tspan x="0" y="13.2" font-family="Robot" font-size="11"></tspan></text>
<text class="r9" transform="matrix(1 0 0 1 396 606.8486)" font-family="Robot" font-size="11">Virus like particles (VLP) vaccine</text>
<text class="r10"  transform="matrix(1 0 0 1 675 411.8643)">

  <tspan x="0" y="0" font-family="Robot" font-size="11">Planning clinical studies </tspan>
  <!-- <tspan x="0" y="13.2" font-family="Robot" font-size="11">clínicos en humanos</tspan> -->
</text>
<text transform="matrix(1 0 0 1 9.5654 645.0947)" font-family="Robot" font-style="italic" font-size="10">Source: ISGlobal, based on data in E  Waltz. GM mosquitoes fire first salvo against Zika virus. Nature Biotechnologies.  March 2016</text>
<rect x="461" y="454.5" fill="none" width="4" height="16"/>
</svg>
